Thieno[2,3-b]pyridine compounds potently inhibit prostate cancer growth and motility
(2025)
Journal Article
Alkheilewi, M. A., Leach, D. A., Mohr, A., Zwacka, R. M., Laissue, P., Metodiev, M., Bevan, C. L., Van Rensburg, M., Pilkington, L. I., Barker, D., Reynisson, J., Brooke, G. N., Alkheilewi, M. A., Mohr, A., Zwacka, R. M., Laissue, P., Metodiev, M., Van Rensburg, M., Pilkington, L. I., & Reynisson, J. (2025). Thieno[2,3-b]pyridine compounds potently inhibit prostate cancer growth and motility. Endocrine Oncology, 5(1), https://doi.org/10.1530/eo-24-0082
Objective Prostate cancer growth is dependent upon androgens and hence therapies often target this signalling axis. These therapies, for example the antiandrogen enzalutamide, are successful in the majority of men; however, resistance is inevitable a... Read More about Thieno[2,3-b]pyridine compounds potently inhibit prostate cancer growth and motility.